• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday

    3/20/24 11:41:03 AM ET
    $ALIT
    $ANVS
    $BAK
    $CLSK
    Real Estate
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALIT alert in real time by email

    U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.

    Shares of Sportradar Group AG (NASDAQ:SRAD) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter results and authorized a $200 million share repurchase program.

    Sportradar posted quarterly earnings of 8 cents per share, beating market estimates of 4 cents per share. The company’s quarterly sales came in at $271.88 million, beating market expectations of $271.46 million, according to data from Benzinga Pro.

    Sportradar Group shares jumped 10.7% to $11.17 on Wednesday.

    Here are some other big stocks recording gains in today’s session.

    • Annovis Bio, Inc. (NASDAQ:ANVS) shares surged 25.6% to $11.21 after the company announced the completion of data cleaning for its Phase 2/3 study of Buntanetap in patients with mild to moderate Alzheimer's disease, with Topline efficacy data expected in April.
    • Taysha Gene Therapies, Inc. (NASDAQ:TSHA) gained 23% to $2.7650 after the company reported a year-over-year increase in FY23 EPS results.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) climbed 18.1% to $43.00.
    • TeraWulf Inc. (NASDAQ:WULF) rose 18% to $2.0297 amid a rise in Bitcoin.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) jumped 16.7% to $3.7600 after the company reported a fourth-quarter fiscal 2023 revenue of $242.6 million, marginally beating the consensus of $242.4 million.
    • Direct Digital Holdings, Inc. (NASDAQ:DRCT) climbed 16.5% to $31.70.
    • Braskem S.A. (NYSE:BAK) climbed 12.7% to $10.13 after the company on Tuesday reported fourth-quarter financial results.
    • LiveWire Group, Inc. (NYSE:LVWR) surged 12.5% to $7.29.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) gained 12.4% to $10.25.
    • LivaNova PLC (NASDAQ:LIVN) climbed 12.3% to $56.55 after the company announced its OSPREY clinical study, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation achieved a 'positive predictive outcome' and will conclude enrollment earlier than anticipated.
    • Topgolf Callaway Brands Corp. (NYSE:MODG) rose 11.8% to $16.11 following a Chosun Daily report suggesting the company is up for sale.
    • Alight, Inc. (NASDAQ:ALIT) gained 11.5% to $9.85 after the company announced an agreement to sell its Payroll & Professional Services business for up to $1.2 billion.
    • ImmunityBio, Inc. (NASDAQ:IBRX) gained 10.5% to $6.00.
    • The Beauty Health Company (NASDAQ:SKIN) climbed 9.3% to $4.3050.
    • CleanSpark, Inc. (NASDAQ:CLSK) rose 7.5% to $17.72.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) gained 7.5% to $20.77 amid a rise in Bitcoin.
    • Paymentus Holdings, Inc. (NYSE:PAY) climbed 6.8% to $23.92.
    • Spirit AeroSystems Holdings, Inc. (NYSE:SPR) rose 6.7% to $35.19.
    • Carvana Co (NYSE:CVNA) climbed 5.3% to $83.07.
    • Chipotle Mexican Grill, Inc. (NYSE:CMG) gained 5.1% to $2,941.41 after company's board approved a 50-for-1 split of common shares.

     

    Now Read This: Disney, JPMorgan And More: CNBC's 'Final Trades'

    Get the next $ALIT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALIT
    $ANVS
    $BAK
    $CLSK

    CompanyDatePrice TargetRatingAnalyst
    Braskem SA ADR
    $BAK
    3/26/2026$2.80Neutral → Underperform
    BofA Securities
    TeraWulf Inc.
    $WULF
    3/23/2026$30.00Buy
    Arete
    Chipotle Mexican Grill Inc.
    $CMG
    3/20/2026$40.00Neutral → Outperform
    Mizuho
    ImmunityBio Inc.
    $IBRX
    3/12/2026$13.00Buy
    BTIG Research
    Chipotle Mexican Grill Inc.
    $CMG
    3/6/2026$51.00Buy
    DA Davidson
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Alight Inc.
    $ALIT
    2/20/2026$1.00Buy → Neutral
    Citigroup
    Paymentus Holdings Inc.
    $PAY
    2/20/2026$35.00Outperform → Strong Buy
    Raymond James
    More analyst ratings

    $ALIT
    $ANVS
    $BAK
    $CLSK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lopes Robert A. Jr. bought $24,600 worth of shares (30,000 units at $0.82), increasing direct ownership by 34% to 117,219 units (SEC Form 4)

    4 - Alight, Inc. / Delaware (0001809104) (Issuer)

    3/17/26 5:32:17 PM ET
    $ALIT
    Real Estate

    Director Bucella Michael C. bought $19,950 worth of shares (1,338 units at $14.91), increasing direct ownership by 0.49% to 273,552 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/13/26 5:49:13 PM ET
    $WULF
    EDP Services
    Technology

    Chief Executive Officer Verma Rohit bought $99,680 worth of shares (112,000 units at $0.89), increasing direct ownership by 11% to 1,134,883 units (SEC Form 4)

    4 - Alight, Inc. / Delaware (0001809104) (Issuer)

    3/12/26 6:12:41 PM ET
    $ALIT
    Real Estate

    $ALIT
    $ANVS
    $BAK
    $CLSK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

    Issued on behalf of VentriPoint Diagnostics Ltd.VANCOUVER, BC, March 27, 2026 /CNW/ -- Equity-Insider.com News Commentary – The traditional hospital model is undergoing a massive structural shift. Outpatient clinics and ambulatory services are quickly becoming the primary growth engines for the entire U.S. healthcare sector. In fact, Ernst & Young's 2026 outlook confirms that these accessible, lower-acuity care segments are attracting the heaviest strategic capital allocations as health systems realign their infrastructure[1]. This powerful momentum is accelerating across the medical technology space. Recent data from NVIDIA's 2026 healthcare survey shows that 70% of organizations are now ac

    3/27/26 10:15:00 AM ET
    $CLOV
    $LIVN
    $MBOT
    Medical Specialities
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Biotechnology: Biological Products (No Diagnostic Substances)

    Alight Commits to Remain on NYSE After Receiving Continued Listing Standard Notice

    The Company's common stock continues to trade on the NYSE under symbol "ALIT" Alight, Inc. (NYSE:ALIT), a leading benefits administration provider of health, wealth, leave and point solutions, announced that on March 24, 2026, it received written notice from the New York Stock Exchange (the "NYSE") that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company's Class A common stock was less than $1.00 per share over the consecutive 30 trading-day period ended March 20, 2026. Alight has responded to the NYSE with respect to its commitment to regain compliance with Rule 802.01C and remain listed on the NYSE. The Compan

    3/27/26 7:30:00 AM ET
    $ALIT
    Real Estate

    Sportradar Files Its Annual Report on Form 20-F

    ST. GALLEN, Switzerland, March 27, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ:SRAD) (the "Company") today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission on March 27, 2026. The annual report on Form 20-F can be accessed on the Company's investor relations website at https://investors.sportradar.com/financials-filings/sec-filings or on the SEC's website at www.sec.gov. The Company will provide a paper copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed in writing by email to in

    3/27/26 7:05:00 AM ET
    $SRAD
    Computer Software: Programming Data Processing
    Technology

    $ALIT
    $ANVS
    $BAK
    $CLSK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Braskem SA downgraded by BofA Securities with a new price target

    BofA Securities downgraded Braskem SA from Neutral to Underperform and set a new price target of $2.80

    3/26/26 8:40:27 AM ET
    $BAK
    Major Chemicals
    Industrials

    Arete initiated coverage on TeraWulf with a new price target

    Arete initiated coverage of TeraWulf with a rating of Buy and set a new price target of $30.00

    3/23/26 8:29:37 AM ET
    $WULF
    EDP Services
    Technology

    Chipotle Mexican Grill upgraded by Mizuho with a new price target

    Mizuho upgraded Chipotle Mexican Grill from Neutral to Outperform and set a new price target of $40.00

    3/20/26 8:28:20 AM ET
    $CMG
    Restaurants
    Consumer Discretionary

    $ALIT
    $ANVS
    $BAK
    $CLSK
    SEC Filings

    View All

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    3/27/26 4:34:16 PM ET
    $BAK
    Major Chemicals
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by TeraWulf Inc.

    SCHEDULE 13G/A - TERAWULF INC. (0001083301) (Subject)

    3/27/26 1:32:18 PM ET
    $WULF
    EDP Services
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Paymentus Holdings Inc.

    SCHEDULE 13G/A - Paymentus Holdings, Inc. (0001841156) (Subject)

    3/27/26 11:19:17 AM ET
    $PAY
    Real Estate

    $ALIT
    $ANVS
    $BAK
    $CLSK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Verma Rohit

    4 - Alight, Inc. / Delaware (0001809104) (Issuer)

    3/26/26 6:36:31 PM ET
    $ALIT
    Real Estate

    SEC Form 4 filed by Felli Martin

    4 - Alight, Inc. / Delaware (0001809104) (Issuer)

    3/26/26 6:36:10 PM ET
    $ALIT
    Real Estate

    SEC Form 4 filed by Dorsey Donna

    4 - Alight, Inc. / Delaware (0001809104) (Issuer)

    3/26/26 6:35:52 PM ET
    $ALIT
    Real Estate

    $ALIT
    $ANVS
    $BAK
    $CLSK
    Financials

    Live finance-specific insights

    View All

    LivaNova to Announce First-Quarter 2026 Results

    LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, will host a conference call to discuss its first-quarter 2026 results on Wed., May 6, 2026, at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its first-quarter 2026 results prior to the call. The audiocast will be accessible at www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To listen to the conference call by telephone, dial +1 833 470 1428 (if dialing from within the U.S.) or +1 929 526 1599 (if dialing from outside the U.S.). The conference call access code is 946097. A replay will be available on the

    3/25/26 9:00:00 AM ET
    $LIVN
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Kingsoft Cloud Announces Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results

    BEIJING, March 25, 2026 /PRNewswire/ -- Kingsoft Cloud Holdings Limited ("Kingsoft Cloud" or the "Company") (NASDAQ:KC), a leading cloud service provider in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Mr. Tao Zou, Chief Executive Officer of Kingsoft Cloud, commented, "We are very pleased to see another strong quarter to close the fiscal year of 2025. Our record-high financial result is a powerful testament to the confidence our customers place in our products, solutions and services. This quarter our gross billing of AI business achieved a year-over-year growth of 95%, and we continue to see strong intelligent computi

    3/25/26 7:57:00 AM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    Taysha Gene Therapies Reports Full-Year 2025 Financial Results and Provides Corporate Update

    Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate ASPIRE trial in three patients aged 2 to <4 years with inclusion of ≥3 months of safety data in planned BLA submission to support potential for broad label; on track to complete dosing in Q2 2026 Maintained favorable tolerability profile with no treatment-related SAEs or DLTs in REVEAL Phase 1/2 and REVEAL pivotal trials as of March 2026 data cutoff; longer-term safety and efficacy data from Part A of REVEAL Phase 1/2 trials expected in Q2 2026 Reached written alignment with FDA on proposed PPQ

    3/19/26 8:00:00 AM ET
    $TSHA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ALIT
    $ANVS
    $BAK
    $CLSK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by Paymentus Holdings Inc.

    SC 13G - Paymentus Holdings, Inc. (0001841156) (Subject)

    12/10/24 5:08:45 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Alight Inc.

    SC 13D/A - Alight, Inc. / Delaware (0001809104) (Subject)

    12/10/24 4:00:22 PM ET
    $ALIT
    Real Estate

    $ALIT
    $ANVS
    $BAK
    $CLSK
    Leadership Updates

    Live Leadership Updates

    View All

    The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era

    VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global immuno-oncology market is set to explode from its current $35 billion level to a massive $185.69 billion by 2035 as the industry moves toward the coordinated activation of the immune system[1]. This surge is being accelerated by the $69.16 billion genomics revolution, which is now integrating advanced profiling into every oncology workflow to pick winning treatments[2]. This strategic push for registration-ready precision assets fuels the 2026 investment case for Oncolytics Biotech Inc. (NASDAQ:ONCY), ImmunityBio (NASDAQ:IBRX), OS Therapies (NYSE-A: OSTX), BioNTech SE (NASDAQ:BNTX),

    1/14/26 10:39:59 AM ET
    $BNTX
    $CMPX
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea

    LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, announced Lucile Blaise has joined the Company as Global Head of Commercialization, Obstructive Sleep Apnea (OSA), effective December 1. Blaise reports to Vladimir Makatsaria, Chief Executive Officer and is a member of the Executive Leadership Team. "Lucile is an accomplished healthcare executive with more than 25 years of leadership in the medtech sector," Makatsaria said. "With her extensive OSA market expertise, she has a strong track record in creating new sleep therapy pathways, improving patient access to care, and building strong commercial teams. Her leadership will help us unlock transformational growth by co

    12/2/25 9:00:00 AM ET
    $LIVN
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care